In this study, we will evaluate the efficacy of intracellular inhibition of HIV infection with a mutant form of Rev, Rev M10. We propose to determine whether Rev M10 can improve the survival of T cells in humans. We plan to accomplish this by introducing the Rev M10 gene into the CD4+ T cells of HIV infected patients, ex vivo. These cells will then be returned to the patient, and their survival measured by PCR.
Showing the most recent 10 out of 1380 publications